Ouro Fino Saúde Animal Participações S A : Institutional Presentation
August 17, 2021 at 10:54 am EDT
Share
Aug 2021
34 year history
1987
2000
2010
2014
2015
2018
2020
Founded by
Entered in
Intensification
foot-and-
of actions
Norival
mouth
abroad
Bonamichi
disease
focusing on
and Jardel
vaccine
Mexico and
Massari
market.
Colombia
.
Inauguration
IPO
Entered into
of biological
At the highest
plant and
the pet
market
level of
launch of the
governance
vaccine of
circovirus.
Implementation
of Strategic
Planning and
Evolution of the
Organizational
Culutre
Animal Health Global Market
USD billions
30
32
34
41
38
36
2018
2019F
2020F
2021F
2022F
2023F
Source: company information
Animal Health in Brazil
Market of
BRL 7.6 billion
(2020)
CAGR (17-20)
12%
78%
51%
Production
22%
CAGR (17-20)
CAGR (17-20)
10%
18 %
14%
2%12%
Others
Source: Company analyzes based on data of Sindan
Highlights
Latin America is responsible for 17% of total meat
production in the world. Brazil answers for 9% (2020).
Markets still incipient in the use of animal health products
Growing need to improve animal productivity as a key driver of demand for animal health products
Source: company information based on data of FAO
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Ourofino Saúde Animal Participações SA published this content on 17 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2021 14:53:09 UTC.
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. 
